Dear Seed Investor,  What a week for our #1 Stock Pick Choom™ (CSE: CHOO; OTCQB: CHOOF)​ as they announce the closing of its acquisition of... Breaking News: Choom™ Announces Closing of Specialty Medijuana Products

Dear Seed Investor, 

What a week for our #1 Stock Pick Choom™ (CSE: CHOO; OTCQB: CHOOF)​ as they announce the closing of its acquisition of Specialty Medijuana Products.  

This follows the announcement earlier this week of a $10 Million placement, with $7 Million coming from Aurora Cannabis, leading to record highs in both stock price and volume.

This closes another Late Stage ACMPR Applicant under the Choom umbrella, and it is expected to receive its cultivation license at any time. 

Not to mention the ability to scale growing facilities and increase production capacity to 700,000 sq ft.

Needless to say, this is more great news for Seed Investors looking for a small cap that is ready to explode. 


Choom™ (CSE: CHOO; OTCQB: CHOOF), an emerging fully-integrated cannabis company, is pleased to announce that today it is closing its acquisition of Specialty Medijuana Products Inc. pursuant to an amended and restated amalgamation agreement among Choom, Arbutus Brands Inc. and International Tungsten Inc. The Company announced the definitive agreement to effect the Transaction in a news release on March 19, 2018.

“We are excited to add SMP to the Choom group of companies under our Arbutus Brands subsidiary,” states Chris Bogart, President and CEO for Choom. “Arbutus Brands will add value to the entire Choom supply chain, from seed to sale. The synergies among our Choom companies will make for an extremely bright and exciting future as we approach the legalization of the recreational cannabis market in Canada.”

Transaction Highlights

The benefits of the Transaction for Choom™ include that it will:

  • Enable Choom™ to acquire SMP, which has submitted its AOR evidence package to Health Canada and expects to receive its cultivation license at any time;
  • Create significant synergies in operational infrastructure and expertise across multiple disciplines to drive strong growth potential;
  • Significantly improve and advance operational scale and production capacity; and
  • Strengthen and accelerate Choom’s strategic direction as a fully-integrated cannabis company, representing a premiere lifestyle brand in Canada.

Specialty Medijuana Products Inc.

SMP, based in Canada’s beautiful Sooke, BC, is committed to becoming a Licensed Producer of cannabis under the ACMPR. SMP was founded by a seasoned business team with extensive experience in growing cannabis, the operation of pharmacies, medical clinics, land development and construction. The SMP team, in conjunction with Choom’s™ management team, plan to build upon their collective past business successes and leverage their expertise to create Canada’s premiere lifestyle brand in adult-use cannabis.

Facility Overview

SMP’s marijuana production growth strategy is expected to be executed in three phases:

  • Phase I – First Facility: AOR evidence package submitted to Health Canada: Building is at operational readiness with state-of-the-art-facilities, consistent with ACMPR standards, and SMP expects to receive its cultivation license from Health Canada in Summer 2018.
  • Phase II – Second Facility: Expand existing production by constructing an approximately 19,600 sq. ft. facility that will bring total production capacity to over 29,000 sq. ft. in the combined facility footprint.
  • Phase III – New Facility: Expand existing production by constructing two additional buildings that will increase the total building gross square footage to just over 700,000 sq. ft. This new facility, a hybrid model of indoor and greenhouse production, is expected to bring Choom’s total production capacity to over 700,000 sq. ft. The Municipality of Sooke has already approved cannabis production zoning for the site. The building expansion fits within the zoning regulations and final planning for this expansion is currently underway.

The Arbutus Team

Arbutus’s team has the experience to ensure that they successfully navigate the ACMPR licensing process and deliver on their vision. The team includes from SMP: 

Michael Forbes

Named one of 2017’s Top Entrepreneurs by Quantum Shift, Michael has a long history of creating and operating successful companies in the pharmaceutical and health care industries. Over the course of 14 years in business, he has created and operated a chain of nine pharmacies and eight medical clinics, including three methadone clinics, employing over 160 people.

This expertise led to him being nominated to help create the procedures for the College of Pharmacists of British Columbia in 2010. His expertise in creating standard operating procedures in the pharmaceutical space is vital in ensuring proper drug dispensing to the public. This experience is crucial in creating trust with the consumer and the industry at large. He holds an Honorary Degree in Business from the Ivey School of Business and a Bachelor of Science, Pharmacy. Mr. Forbes will be joining the Choom™ Board of Directors upon the completion of the Transaction.

Ian Laing

Ian has over 20 years of experience in real estate, development and construction in a range of areas, including apartment buildings, custom home construction, land development, rezoning, condominiums, commercial and industrial buildings.

Since 1998, Ian has consistently proven his ability to build and grow multimillion-dollar projects from the ground up. He has a background in Urban Land Economics from the University of British Columbia and a commitment to building with integrity. Ian is currently running four companies and has experience in the recreational space with Salt Spring Island Brewery. This experience is expected to benefit the development of SMP’s business practices and the anticipated build out and scaling of facilities. SMP will rely on this expertise as it grows its facilities and expands operations.

Neil Michael MacLean

Neil MacLean has over 20 years of experience with the Department of National Defence (“DND”), primarily dealing with electronics, and previously was an environmental officer for HMCS Huron. His safety and WHMIS training, combined with his understanding of security procedures, are expected to assist SMP with compliance with the highest level of government regulations. He has effectively managed the integration of new equipment and systems, and has extensive personnel training experience, which, together with his training in environmental issues, electronics and operations of complex systems, will support the operational side of SMP. 

Transaction Details

In connection with the completion of the Transaction and pursuant to the amended and restated amalgamation agreement:

  • Choom will issue 52,031,110 Choom Shares and 39,968,890 Choom Share Commitments to the former holders of common shares and special warrants of International Tungsten Inc.
  • Each Choom Share Commitment will convert into either one Choom Share or three-quarters of a Choom Share depending on the grant date of the SMP cultivation license and such Choom Shares will be subject to a three year escrow release from closing
  • Choom will issue 1,000,000 stock options
  • Choom will issue 4,000,000 Common Shares to finders

On completion of the Transaction, SMP will become an indirect subsidiary of Choom through Choom’s direct subsidiary Arbutus Brands.


The Choom brand is inspired by Hawaii’s “Choom Gang”- a group of buddies in Honolulu during the 1970’s who loved to smoke weed—or as the locals called it, choom. Evoking the spirit of the original Choom Gang, our brand is synonymous with cultivating good times with good friends. We are focused on delivering an elevated customer experience through our curated retail environments, high-grade handcrafted cannabis supply, and a diversity of brands for the Canadian recreational consumer.

“Chris Bogart”

President & CEO

Contact: Choom Holdings Inc.
Chris Bogart

President & CEO

T: 604.683.2509

F: 604.683.2506


Alex Porporo

Investor Relations

T: 604.683.2509

F: 604.683.2506



Please see full disclaimers at applicable to all content provided by TSI, wherever published or re-published:

Disclaimer: This release/advertorial is a commercial advertisement and is for general information purposes only. This release/advertorial does not constitute an offer or solicitation to buy or sell any securities or individualized investment advice. This is a native advertisement, meaning it is an informational paid marketing piece. (TSI) makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Please review all investment decisions with a licensed investment advisor. TSI receives payments ranging from approximately $25,000 to $150,000 to publish and/or distribute advertisements on behalf of a company. TSI retains any excess sums after expenses as its compensation. and its owners, operators and affiliates may benefit from any increase in the share prices of the profiled companies. may be paid for services using options or free-trading shares. and/or its owners, operators and affiliates may be selling shares of stock at the same time the profile (or other information) is being disseminated to potential investors; will not advise when it or its affiliates decide to sell. Investors must make all investment decisions based on their own judgment of the market and the particular securities.

This advertorial contains forward-looking statements that involve risks and uncertainties. This advertorial contains or incorporates by reference forward-looking statements, including certain information with respect to plans and strategies of the featured company. As such, any statements contained herein or incorporated herein by reference that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words “believe(s),” “anticipate(s),” “plan(s),” “expect(s),” “project(s),” “will,” “make,” “told,” “could,” “might,” and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause actual events or actual results of the company to differ materially from these indicated by such forward-looking statements. Certain statements contained herein are forward-looking statements as defined in Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Such statements include, without limitation, statements regarding business, financing, business trends, future operating revenues and expenses. There can be no assurance that such expectations will prove to be correct. Investors are cautioned that any forward-looking statements made by the company, or contained in this advertorial are not guarantees of future performance, and that the issuer’s actual results may differ materially from those set forth in the forward-looking statements. We undertake no obligation to update any statements made herein except as required by law. Differences in results can be caused by various factors including, but not limited to, the company’s ability to be able to successfully complete planned funding agreements, to successfully market its products in competitive industries or to effectively implement its business plan or strategies. To reiterate, information presented in this advertorial contains “forward-looking statements.” Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact and may be “forward-looking statements.” Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. More information on the company may be found at where readers can review all public filings submitted by the company. is not a certified financial analyst or licensed in the securities industry in any manner. The information in this advertorial is subjective opinion and may not be complete, accurate or current and was paid for, so this could create a conflict of interest. Read Full Disclaimer at

MJ Shareholders avatar

MJ Shareholders is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers

( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )